Morning Overview on MSN

Leftover COVID-19 fragments found silently killing key immune cells

Long after the acute infection fades, pieces of the virus behind COVID-19 can linger in the body and quietly sabotage the ...
Medscape

FDA Breakthrough Therapy Designation Granted for Litifilimab for Cutaneous Lupus

Litifilimab, a humanized immunoglobulin G1 monoclonal antibody that targets blood dendritic cell antigen 2, has been granted ...
ScienceAlert on MSN

'Zombie' remnants of COVID-19 hunt in packs and kill our immune cells

'Zombie' coronavirus fragments not only help drive inflammation in long-COVID, but also destroy our immune cells. A recent study by an international team of more than 30 authors reveals how the ...

Dad's complaints about stomach aches led to devastating diagnosis

Tom Hayman wasn’t feeling himself around the summer of 2024 and couldn’t shake the feeling it was something serious ...

Identifying mechanisms that support nanoparticle therapy for autoimmune diseases

Northwestern Medicine scientists in the laboratory of Stephen Miller, Ph.D., professor emeritus of Microbiology–Immunology, have identified the cellular and molecular mechanisms required for the ...
Technology Networks

SARS-CoV-2 Fragments Attack Key Immune Cells, Explaining Severe COVID

Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...
Frontiers

Modeling and Engineering T Cells: From Systems Understanding to Next-Generation Immunotherapies

T cells sit at the center of modern immunotherapy, yet many of the rules that govern their activation, differentiation, dysfunction (e.g., exhaustion), and ...